| Trial ID: | L0014 |
| Source ID: | NCT00194883
|
| Associated Drug: |
Recombinant Human Growth Hormone
|
| Title: |
Effect of Cytokines on Growth of Children With Chronic Kidney Failure
|
| Acronym: |
|
| Status: |
SUSPENDED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Insufficiency
|
| Interventions: |
DRUG: Recombinant Human Growth Hormone
|
| Outcome Measures: |
Primary: To examine the efficacy of recombinant human growth hormone in improving growth velocity in prepubertal children with growth failure secondary to chronic kidney disease. | Secondary: To examine how recombinant human growth hormone effects body composition, the GH-IGF axis proteins and biochemical/immunological parameters in children with growth failure secondary to chronic kidney disease
|
| Sponsor/Collaborators: |
Sponsor: Weill Medical College of Cornell University | Collaborators: Genentech, Inc.
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
1997-04
|
| Completion Date: |
2003-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-11-21
|
| Locations: |
Weill Medical College of Cornell University, New York, New York, 10021, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00194883
|
